Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes.
INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
A
A
Moutairou
INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Diabetology, Endocrinology and Nutrition Department, DHU FIRE, Hôpital Bichat, AP-HP, Paris, France.
R
R
Roussel
Faculté de Médecine, Université de Nantes, Nantes, France.
B
B
Charbonnel
Service Médecine Interne/Endocrinologie-Diabétologie, CHN de Pikine, Faculté de Médecine de Dakar, Dakar, Senegal.
A
A
Leye
CEMKA-EVAL, Bourg-La-Reine, France.
B
B
Detournay
INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Diabetology, Endocrinology and Nutrition Department, DHU FIRE, Hôpital Bichat, AP-HP, Paris, France.
K
K
Mohammedi
INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Diabetology, Endocrinology and Nutrition Department, DHU FIRE, Hôpital Bichat, AP-HP, Paris, France. Electronic address: louis.potier@gmail.com.
L
L
Potier
D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D055815:Young Adult
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin